A 41‑year‑old Colorado nonprofit CEO was diagnosed with small‑cell lung cancer after coughing up blood in December 2023 and is now responding to the experimental drug Imdelltra.
Posts tagged as “Immunotherapy”
Brigham Young University scientists say their MOTO‑CAR platform cut aggressive lung cancer cells by 90% in lab tests, highlighting a potential low‑cost immunotherapy route.
The first drug capable of delaying the onset of type 1 diabetes, Teplizumab, is now accessible on the NHS in England and Wales, offering potential years without insulin treatment.


